Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 8-c-beta-glucopyranosyl-3',4',5,7-tetrahydroxyflav-2-en-3-one
2. Luteolin 8-c-beta-d-glucopyranoside
3. Luteolin-8-c-glucoside
4. Orientine
1. 28608-75-5
2. Lutexin
3. Luteolin 8-c-glucoside
4. Orientine
5. Luteolin-8-glucoside
6. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-beta-d-glucopyranosyl-5,7-dihydroxy-
7. 8-beta-d-glucosylluteolin
8. Iax93xcw6c
9. Luteolin 8-glucoside
10. Chebi:7781
11. 2-(3,4-dihydroxyphenyl)-8-beta-d-glucopyranosyl-5,7-dihydroxy-4h-1-benzopyran-4-one
12. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-4h-chromen-4-one
13. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
14. C10114
15. Orientin (flavone)
16. 8-glucosylluteolin
17. Luteolin-8-c-glucoside
18. 2-(3,4-dihydroxyphenyl)-8-beta-d-glucopyranosyl-5,7-dihydroxy-4h-chromen-4-one
19. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-.beta.-d-glucopyranosyl-5,7-dihydroxy-
20. Unii-iax93xcw6c
21. Nsc-133101
22. Use
23. Mfcd00017432
24. 8-.beta.-d-glucopyranosyl-3',4',5,7-tetrahydroxyflavone
25. Schembl25942
26. Orientin, Analytical Standard
27. Massbank Pr020063
28. Chembl520866
29. Orientin, >=97% (hplc)
30. Bdbm84982
31. Dtxsid60182790
32. Luteolin 8-c-b-d-glucopyranoside
33. Niaid Aids# 026706
34. Hms3886j16
35. Hy-n0405
36. Zinc4098560
37. 8-.beta.-d-glucosylluteolin
38. S9099
39. Akos015896746
40. Ccg-269214
41. Ncgc00482848-01
42. Ac-34280
43. As-73888
44. J17.734b
45. Luteolin 8-c-.beta.-glucopyranoside
46. Cs-0008937
47. O0503
48. Luteolin 8-c-.beta.-d-glucopyranoside
49. 608o755
50. A819507
51. Orientin, Primary Pharmaceutical Reference Standard
52. Q421676
53. 8-b-d-glucopyranosyl-3',4',7'-tetrahydroxyflavone
54. Q-100362
55. 2-(3,4-dihydroxyphenyl)-8-.beta.-d-glucopyranosyl-5,7-dihydroxy-4h-chromen-4-one
56. (1s)-1,5-anhydro-1-(2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-8-yl)-d-glucitol
57. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-(.beta.-d-glucopyranosyl)-4h-1-benzopyran-4-one
58. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4h-chromen-4-one
59. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one
60. 2-(3,4-dihydroxyphenyl)-8-.beta.-d-glucopyranosyl-5,7-dihydroxy-4h-1-benzopyran-4-one
61. 2-[3,4-bis(oxidanyl)phenyl]-8-[(2~{s},3~{r},4~{r},5~{s},6~{r})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]-5,7-bis(oxidanyl)chromen-4-one; 5281675; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
62. 8-(.beta.-d-glucopyranosyl)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
63. D-glucitol, 1,5-anhydro-1-c-(2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-1-benzopyran-8-yl)-, (1s)-
| Molecular Weight | 448.4 g/mol |
|---|---|
| Molecular Formula | C21H20O11 |
| XLogP3 | -0.2 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 3 |
| Exact Mass | 448.10056145 g/mol |
| Monoisotopic Mass | 448.10056145 g/mol |
| Topological Polar Surface Area | 197 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 729 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
61
PharmaCompass offers a list of Orientin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Orientin manufacturer or Orientin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Orientin manufacturer or Orientin supplier.
PharmaCompass also assists you with knowing the Orientin API Price utilized in the formulation of products. Orientin API Price is not always fixed or binding as the Orientin Price is obtained through a variety of data sources. The Orientin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Orientin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Orientin, including repackagers and relabelers. The FDA regulates Orientin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Orientin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Orientin supplier is an individual or a company that provides Orientin active pharmaceutical ingredient (API) or Orientin finished formulations upon request. The Orientin suppliers may include Orientin API manufacturers, exporters, distributors and traders.
Orientin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Orientin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Orientin GMP manufacturer or Orientin GMP API supplier for your needs.
A Orientin CoA (Certificate of Analysis) is a formal document that attests to Orientin's compliance with Orientin specifications and serves as a tool for batch-level quality control.
Orientin CoA mostly includes findings from lab analyses of a specific batch. For each Orientin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Orientin may be tested according to a variety of international standards, such as European Pharmacopoeia (Orientin EP), Orientin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Orientin USP).
